| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268665 | Journal of Clinical Virology | 2005 | 6 Pages |
Abstract
Conclusions: The data show a 3-fold reduction in the infection risk between 1993 and 1995, when the serological screening for HCVin blood donors was being introduced. A reduction greater than 90% was achieved by 1995 when the screening coverage reached 99%.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mauricio Beltrân, Maria-Cristina Navas, Fernando De la Hoz, Maria Mercedes Muñoz, Sergio Jaramillo, Cecilia Estrada, Lucia del Pilar Cortés, Maria Patricia Arbelâez, Jorge Donado, Gloria Barco, Martha Luna, Gustavo Adolfo Uribe, Amalia de Maldonado,